Monday, May 18, 1998 FULL SHOW | HEADLINES | PREVIOUS: Update On Plowshares Activists
1998-05-18

Jeremy Rifkin Discusses Biotechnology

download:   Get CD/DVD More Formats
DONATE →
This is viewer supported news

In his provocative and far-reaching work, Jeremy Rifkin argues that the computer revolution is merely a prelude to a far more significant change taking place in the global economy — a historic transition into the Age of Biotechnology.

The Biotech Century promises genetically engineered plants and animals to feed a hungry world; wonder drugs and genetic therapies to produce healthier babies, eliminate human suffering, and extend the human life span. But with every step we take into this Brave New World, the nagging question persists — At what cost?

The new genetic commerce raises more troubling questions than any other economic revolution in history. Will the artificial creation of cloned animals mean the end of nature? Will the mass release of thousands of genetically engineered life forms into the environment cause catastrophic damage to the biosphere? What will it mean to live in a world where babies are genetically engineered and customized in the womb? What are the risks we take in attempting to design more "perfect" human beings?

Guests:

  • Jeremy Rifkin, Jeremy Rifkin is the author of 14 books on economic trends and matters relating to science, technology, and culture, including his latest ??The Biotech Century, published by Tarcher/Putnam Press. He is president of the Foundation on Economic Trends in Washington, D.C.

??
.
.
.
??

Recent Shows More

Full News Hour

Stories

Headlines

    There are no headlines for this date.


Creative Commons License The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.